Myriad Genetics (MYGN) Interest Coverage Ratio Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Interest Coverage Ratio Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -109.02% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -7.07% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 20.57% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 13.44% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -33.07% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 54.28% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -10.94% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 32.75% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 0.43% |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn | 79.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.34% |
| Dec 31, 2025 | 97.67% |
| Sep 30, 2025 | 75.47% |
| Jun 30, 2025 | -381.02% |
| Mar 31, 2025 | 35.04% |
| Dec 31, 2024 | -59.69% |
| Sep 30, 2024 | 58.40% |
| Jun 30, 2024 | 79.94% |
| Mar 31, 2024 | 46.55% |
| Dec 31, 2023 | 39.85% |
| Sep 30, 2023 | -6.84% |
| Jun 30, 2023 | -666.52% |
| Mar 31, 2023 | -267.03% |
| Dec 31, 2022 | 32.71% |
| Sep 30, 2022 | 22.56% |
| Jun 30, 2022 | -185.26% |
| Mar 31, 2022 | -82.73% |
| Dec 31, 2021 | -469.43% |
| Sep 30, 2021 | -431.93% |
| Jun 30, 2021 | 52.80% |